| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-05-22 14:17:29 UTC |
|---|
| Update Date | 2023-02-21 17:15:59 UTC |
|---|
| HMDB ID | HMDB0001967 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Carbon dioxide |
|---|
| Description | Carbon dioxide is a colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbon dioxide is produced during respiration by all animals, fungi and microorganisms that depend on living and decaying plants for food, either directly or indirectly. It is, therefore, a major component of the carbon cycle. Additionally, carbon dioxide is used by plants during photosynthesis to make sugars which may either be consumed again in respiration or used as the raw material to produce polysaccharides such as starch and cellulose, proteins and the wide variety of other organic compounds required for plant growth and development. When inhaled at concentrations much higher than usual atmospheric levels, it can produce a sour taste in the mouth and a stinging sensation in the nose and throat. These effects result from the gas dissolving in the mucous membranes and saliva, forming a weak solution of carbonic acid. Carbon dioxide is used by the food industry, the oil industry, and the chemical industry. Carbon dioxide is used to produce carbonated soft drinks and soda water. Traditionally, the carbonation in beer and sparkling wine comes about through natural fermentation, but some manufacturers carbonate these drinks artificially. |
|---|
| Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| [CO2] | ChEBI | | Carbonic anhydride | ChEBI | | CO2 | ChEBI | | e 290 | ChEBI | | e-290 | ChEBI | | e290 | ChEBI | | R-744 | ChEBI | | Carbon oxide | HMDB | | Carbon-12 dioxide | HMDB | | Carbonic acid anhydride | HMDB | | Carbonic acid gas | HMDB | | Anhydride, carbonic | HMDB | | Dioxide, carbon | HMDB |
|
|---|
| Chemical Formula | CO2 |
|---|
| Average Molecular Weight | 44.0095 |
|---|
| Monoisotopic Molecular Weight | 43.989829244 |
|---|
| IUPAC Name | methanedione |
|---|
| Traditional Name | carbon dioxide |
|---|
| CAS Registry Number | 124-38-9 |
|---|
| SMILES | O=C=O |
|---|
| InChI Identifier | InChI=1S/CO2/c2-1-3 |
|---|
| InChI Key | CURLTUGMZLYLDI-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of inorganic compounds known as other non-metal oxides. These are inorganic compounds containing an oxygen atom of an oxidation state of -2, in which the heaviest atom bonded to the oxygen belongs to the class of 'other non-metals'. |
|---|
| Kingdom | Inorganic compounds |
|---|
| Super Class | Homogeneous non-metal compounds |
|---|
| Class | Other non-metal organides |
|---|
| Sub Class | Other non-metal oxides |
|---|
| Direct Parent | Other non-metal oxides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Other non-metal oxide
- Inorganic oxide
|
|---|
| Molecular Framework | Not Available |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Liquid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | -56.5 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 1.48 mg/mL at 25 °C | Not Available | | LogP | 0.83 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross Sections| Predictor | Adduct Type | CCS Value (Å2) | Reference |
|---|
| DeepCCS | [M+H]+ | 114.994 | 30932474 | | DeepCCS | [M-H]- | 113.187 | 30932474 | | DeepCCS | [M-2H]- | 148.485 | 30932474 | | DeepCCS | [M+Na]+ | 122.227 | 30932474 |
Predicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 9.9727 minutes | 33406817 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 250.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 851.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 421.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 186.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 343.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 180.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 307.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 436.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 534.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 645.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 175.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 807.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 276.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 367.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 705.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 346.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 285.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Carbon dioxide | O=C=O | 775.9 | Standard polar | 33892256 | | Carbon dioxide | O=C=O | 234.5 | Standard non polar | 33892256 | | Carbon dioxide | O=C=O | 384.0 | Semi standard non polar | 33892256 |
|
|---|
| Spectra |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Carbon dioxide EI-B (Non-derivatized) | splash10-0006-9000000000-ffb540455919d1e43969 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Carbon dioxide EI-B (Non-derivatized) | splash10-0006-9000000000-ffb540455919d1e43969 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Carbon dioxide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9000000000-9afc44eaa1fe34c4f458 | 2016-09-22 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Carbon dioxide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Carbon dioxide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-0006-9000000000-e1cf88df1066f206d01f | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbon dioxide 10V, Positive-QTOF | splash10-0006-9000000000-eb2207f7400e9144fff7 | 2015-05-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbon dioxide 20V, Positive-QTOF | splash10-0006-9000000000-eb2207f7400e9144fff7 | 2015-05-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbon dioxide 40V, Positive-QTOF | splash10-0006-9000000000-eb2207f7400e9144fff7 | 2015-05-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbon dioxide 10V, Negative-QTOF | splash10-0006-9000000000-b7e6c1e22f1f90c5a8e0 | 2015-05-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbon dioxide 20V, Negative-QTOF | splash10-0006-9000000000-b7e6c1e22f1f90c5a8e0 | 2015-05-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbon dioxide 40V, Negative-QTOF | splash10-0006-9000000000-b7e6c1e22f1f90c5a8e0 | 2015-05-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbon dioxide 10V, Positive-QTOF | splash10-0006-9000000000-a1e091bb1f5fa6e9cbc7 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbon dioxide 20V, Positive-QTOF | splash10-0006-9000000000-a1e091bb1f5fa6e9cbc7 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carbon dioxide 40V, Positive-QTOF | splash10-0006-9000000000-a1e091bb1f5fa6e9cbc7 | 2021-09-24 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|
| Biological Properties |
|---|
| Cellular Locations | - Cytoplasm
- Extracellular
- Mitochondria
- Nucleus
- Endoplasmic reticulum
- Golgi apparatus
- Peroxisome
|
|---|
| Biospecimen Locations | |
|---|
| Tissue Locations | |
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 20900.0 +/- 1100.0 uM | Children (1-13 years old) | Not Specified | Normal | | details | | Blood | Detected and Quantified | 21600.0 +/- 600.0 uM | Adult (>18 years old) | Male | Normal | | details | | Blood | Detected and Quantified | 25600.0 +/- 1430.0 uM | Adult (>18 years old) | Female | Normal | | details | | Blood | Detected and Quantified | 17000.00 (11100.0-21200.0) uM | Newborn (0-30 days old) | Both | Normal | | details | | Blood | Detected and Quantified | 5000-20000 uM | Newborn (0 - <14 days old) | Both | Normal | | details | | Blood | Detected and Quantified | 10000-24000 uM | Infant (15 days - <1 year old) | Both | Normal | | details | | Blood | Detected and Quantified | 14000-24000 uM | Children (1 - <5 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 17000-26000 uM | Children (5 - 15 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 17000-26000 uM | Adolescent (15 - 19 years old) | Female | Normal | | details | | Blood | Detected and Quantified | 18000-28000 uM | Adolescent (15 - 19 years old) | Male | Normal | | details | | Blood | Detected and Quantified | 21000-31000 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 18000-27000 uM | Children (1-13 years old) | Not Specified | Normal | | details | | Blood | Detected and Quantified | 24000-35000 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Blood | Detected and Quantified | 18000-24000 uM | Children (1-13 years old) | Not Specified | Normal | | details | | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 32000 (28000-36000) uM | Children (1-13 years old) | Both | Bartter Syndrome, Type 3 | | details | | Blood | Detected and Quantified | 5000 uM | Infant (0-1 year old) | Female | Fructose-1,6-bisphosphatase deficiency | | details | | Blood | Detected and Quantified | 16000 uM | Infant (0-1 year old) | Female | Long-chain Fatty Acids, Defect in Transport of | | details | | Blood | Detected and Quantified | 24000 (18000-30000) uM | Children (1-13 years old) | Not Specified | Oculocerebrorenal Syndrome of Lowe | | details | | Blood | Detected and Quantified | 13000 uM | Children (1-13 years old) | Female | Pearson Syndrome | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Bartter Syndrome, Type 3 |
|---|
- Seys E, Andrini O, Keck M, Mansour-Hendili L, Courand PY, Simian C, Deschenes G, Kwon T, Bertholet-Thomas A, Bobrie G, Borde JS, Bourdat-Michel G, Decramer S, Cailliez M, Krug P, Cozette P, Delbet JD, Dubourg L, Chaveau D, Fila M, Jourde-Chiche N, Knebelmann B, Lavocat MP, Lemoine S, Djeddi D, Llanas B, Louillet F, Merieau E, Mileva M, Mota-Vieira L, Mousson C, Nobili F, Novo R, Roussey-Kesler G, Vrillon I, Walsh SB, Teulon J, Blanchard A, Vargas-Poussou R: Clinical and Genetic Spectrum of Bartter Syndrome Type 3. J Am Soc Nephrol. 2017 Aug;28(8):2540-2552. doi: 10.1681/ASN.2016101057. Epub 2017 Apr 5. [PubMed:28381550 ]
| | Fructose-1,6-diphosphatase deficiency |
|---|
- Pagliara AS, Karl IE, Keating JP, Brown BI, Kipnis DM: Hepatic fructose-1,6-diphosphatase deficiency. A cause of lactic acidosis and hypoglycemia in infancy. J Clin Invest. 1972 Aug;51(8):2115-23. doi: 10.1172/JCI107018. [PubMed:4341015 ]
| | Long-chain Fatty Acids, Defect in Transport of |
|---|
- Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM: Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988 Nov 17;319(20):1331-6. doi: 10.1056/NEJM198811173192006. [PubMed:3185635 ]
| | Oculocerebrorenal syndrome |
|---|
- Charnas LR, Bernardini I, Rader D, Hoeg JM, Gahl WA: Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med. 1991 May 9;324(19):1318-25. doi: 10.1056/NEJM199105093241904. [PubMed:2017228 ]
| | Pearson Syndrome |
|---|
- Crippa BL, Leon E, Calhoun A, Lowichik A, Pasquali M, Longo N: Biochemical abnormalities in Pearson syndrome. Am J Med Genet A. 2015 Mar;167A(3):621-8. doi: 10.1002/ajmg.a.36939. [PubMed:25691415 ]
|
|
|---|
| Associated OMIM IDs | - 607364 (Bartter Syndrome, Type 3)
- 229700 (Fructose-1,6-diphosphatase deficiency)
- 603376 (Long-chain Fatty Acids, Defect in Transport of)
- 309000 (Oculocerebrorenal syndrome)
- 557000 (Pearson Syndrome)
|
|---|
| External Links |
|---|
| DrugBank ID | DB09157 |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB014084 |
|---|
| KNApSAcK ID | Not Available |
|---|
| Chemspider ID | 274 |
|---|
| KEGG Compound ID | C00011 |
|---|
| BioCyc ID | CARBON-DIOXIDE |
|---|
| BiGG ID | 33506 |
|---|
| Wikipedia Link | Carbon_dioxide |
|---|
| METLIN ID | 3199 |
|---|
| PubChem Compound | 280 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 16526 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | CO2 |
|---|
| MarkerDB ID | MDB00013444 |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Callahan, Richard A. Process and apparatus for producing liquid carbon dioxide. U.S. (1993), Patent US5233837 (https://patents.google.com/patent/US5233837) |
|---|
| Material Safety Data Sheet (MSDS) | Download (PDF) |
|---|
| General References | Not Available |
|---|